Published in Parasitology on July 01, 1998
Identification and differentiation of Leishmania species in clinical samples by PCR amplification of the miniexon sequence and subsequent restriction fragment length polymorphism analysis. J Clin Microbiol (2003) 1.96
Culture-independent species typing of neotropical Leishmania for clinical validation of a PCR-based assay targeting heat shock protein 70 genes. J Clin Microbiol (2004) 1.75
Molecular epidemiology of Leishmania (Viannia) guyanensis in French Guiana. J Clin Microbiol (2006) 1.33
Use of PCR-restriction fragment length polymorphism analysis to identify the main new world Leishmania species and analyze their taxonomic properties and polymorphism by application of the assay to clinical samples. J Clin Microbiol (2006) 1.29
gp63 homologues in Trypanosoma cruzi: surface antigens with metalloprotease activity and a possible role in host cell infection. Infect Immun (2003) 1.04
Species typing in dermal leishmaniasis. Clin Microbiol Rev (2015) 0.97
Association of the Endobiont Double-Stranded RNA Virus LRV1 With Treatment Failure for Human Leishmaniasis Caused by Leishmania braziliensis in Peru and Bolivia. J Infect Dis (2015) 0.95
The associations of Leishmania major and Leishmania tropica aspects by focusing their morphological and molecular features on clinical appearances in Khuzestan Province, Iran. Biomed Res Int (2014) 0.83
Characterization of Leishmania (Leishmania) waltoni n.sp. (Kinetoplastida: Trypanosomatidae), the Parasite Responsible for Diffuse Cutaneous Leishmaniasis in the Dominican Republic. Am J Trop Med Hyg (2015) 0.81
AFLP polymorphisms allow high resolution genetic analysis of American Tegumentary Leishmaniasis agents circulating in Panama and other members of the Leishmania genus. PLoS One (2013) 0.81
Study of Genetic Variation of Leishmania major Based on Internal Transcribed Spacer 1 (ITS1) in Chabahar, Iran. Jundishapur J Microbiol (2016) 0.75
Phylogenetic analysis of HSP70 and cyt b gene sequences for Chinese Leishmania isolates and ultrastructural characteristics of Chinese Leishmania sp. Parasitol Res (2016) 0.75
Naturally occurring antibodies devoid of light chains. Nature (1993) 7.35
High-resolution minisatellite-based typing as a portable approach to global analysis of Mycobacterium tuberculosis molecular epidemiology. Proc Natl Acad Sci U S A (2001) 6.97
A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI. Mem Inst Oswaldo Cruz (2009) 4.27
Selection and identification of single domain antibody fragments from camel heavy-chain antibodies. FEBS Lett (1997) 3.18
A VSG expression site-associated gene confers resistance to human serum in Trypanosoma rhodesiense. Cell (1998) 3.08
The yeast Candida albicans has a clonal mode of reproduction in a population of infected human immunodeficiency virus-positive patients. Proc Natl Acad Sci U S A (1993) 2.94
Gene duplication and transposition linked to antigenic variation in Trypanosoma brucei. Proc Natl Acad Sci U S A (1981) 2.66
Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme. Nat Struct Biol (1996) 2.54
Genetic diversity, clonality and sexuality in Toxoplasma gondii. Int J Parasitol (2004) 2.54
Natural populations of Trypanosoma cruzi, the agent of Chagas disease, have a complex multiclonal structure. Proc Natl Acad Sci U S A (1986) 2.48
Role of genomic typing in taxonomy, evolutionary genetics, and microbial epidemiology. Clin Microbiol Rev (2001) 2.37
Parity among the randomly amplified polymorphic DNA method, multilocus enzyme electrophoresis, and Southern blot hybridization with the moderately repetitive DNA probe Ca3 for fingerprinting Candida albicans. J Clin Microbiol (1997) 2.35
Trypanosoma brucei spp. development in the tsetse fly: characterization of the post-mesocyclic stages in the foregut and proboscis. Parasitology (1999) 2.09
Identification of six Trypanosoma cruzi phylogenetic lineages by random amplified polymorphic DNA and multilocus enzyme electrophoresis. Int J Parasitol (2000) 2.03
Identification of a nuclear and of a cytoplasmic polypeptide whose relative proportions are sensitive to changes in the rate of cell proliferation. Exp Cell Res (1981) 1.99
Sequence and structure of VH domain from naturally occurring camel heavy chain immunoglobulins lacking light chains. Protein Eng (1994) 1.85
Molecular dipstick test for diagnosis of sleeping sickness. J Clin Microbiol (2006) 1.84
Characterisation of large and small subunit rRNA and mini-exon genes further supports the distinction of six Trypanosoma cruzi lineages. Int J Parasitol (2001) 1.81
A rabbit with the allotypic phenotype: ala2a3 b4b5b6. J Immunol (1974) 1.77
Diagnosis of Leishmania using the polymerase chain reaction: a simplified procedure for field work. Am J Trop Med Hyg (1993) 1.68
Visceral leishmaniasis in a German child who had never entered a known endemic area: case report and review of the literature. Clin Infect Dis (2000) 1.63
A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients. Clin Infect Dis (2004) 1.59
Population structure and genetic typing of Trypanosoma cruzi, the agent of Chagas disease: a multilocus enzyme electrophoresis approach. Parasitology (2000) 1.59
Association of Trk neurotrophin receptors with components of the cytoplasmic dynein motor. J Neurosci (2001) 1.53
Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator. Clin Infect Dis (2001) 1.53
Linkage disequilibrium in natural populations of Trypanosoma cruzi (flagellate), the agent of Chagas' disease. J Protozool (1988) 1.48
Prevalence of virulence genes and clonality in Escherichia coli strains that cause bacteremia in cancer patients. Infect Immun (2000) 1.47
Visceral leishmaniasis control: a public health perspective. Trans R Soc Trop Med Hyg (2000) 1.46
Treatment of cutaneous leishmaniasis with oral itraconazole. Int J Dermatol (1994) 1.42
Operational validation of the direct agglutination test for diagnosis of visceral leishmaniasis. Am J Trop Med Hyg (1999) 1.41
Predicted and observed alleles of Plasmodium falciparum merozoite surface protein-1 (MSP-1), a potential malaria vaccine antigen. Mol Biochem Parasitol (1998) 1.40
American tegumentary leishmaniasis: antigen-gene polymorphism, taxonomy and clinical pleomorphism. Infect Genet Evol (2005) 1.39
At least two transposed sequences are associated in the expression site of a surface antigen gene in different trypanosome clones. Cell (1983) 1.35
Two variant surface glycoproteins of Trypanosoma brucei have a conserved C-terminus. Nature (1981) 1.35
Methicillin-resistant Staphylococcus aureus: phylogenetic relatedness between European epidemic clones and Swiss sporadic strains. Microb Drug Resist (2000) 1.34
First tsetse fly transmission of the "AnTat" serodeme of Trypanosoma brucei. Ann Soc Belg Med Trop (1977) 1.34
Efficacy and toxicity of sodium stibogluconate for mucosal leishmaniasis. Ann Intern Med (1990) 1.34
Heat-shock protein 70 PCR-RFLP: a universal simple tool for Leishmania species discrimination in the New and Old World. Parasitology (2010) 1.33
Randomized, double-blind clinical trial of topical imiquimod 5% with parenteral meglumine antimoniate in the treatment of cutaneous leishmaniasis in Peru. Clin Infect Dis (2005) 1.32
The serum resistance-associated (SRA) gene of Trypanosoma brucei rhodesiense encodes a variant surface glycoprotein-like protein. Mol Biochem Parasitol (1994) 1.32
Significant linkage disequilibrium and high genetic diversity in a population of Plasmodium falciparum from an area (Republic of the Congo) highly endemic for malaria. Am J Trop Med Hyg (2003) 1.30
Camel heavy-chain antibodies: diverse germline V(H)H and specific mechanisms enlarge the antigen-binding repertoire. EMBO J (2000) 1.28
First molecular epidemiology study of Mycobacterium tuberculosis in Burkina Faso. J Clin Microbiol (2007) 1.27
Isozyme evidence of lack of speciation between wild and domestic Triatoma infestans (Heteroptera: Reduviidae) in Bolivia. J Med Entomol (1987) 1.27
Survey of Bartonella species infecting intradomicillary animals in the Huayllacallán Valley, Ancash, Peru, a region endemic for human bartonellosis. Am J Trop Med Hyg (1999) 1.27
Environmental risk factors for clinical malaria: a case-control study in the Grau region of Peru. Trans R Soc Trop Med Hyg (2002) 1.23
Clinical pleiomorphism in human leishmaniases, with special mention of asymptomatic infection. Clin Microbiol Infect (2011) 1.22
Environmental factors as determinants of malaria risk. A descriptive study on the northern coast of Peru. Trop Med Int Health (2002) 1.22
Diagnosis of African and American trypanosomiases. Br Med Bull (1985) 1.22
Prospective evaluation and comparison of the direct agglutination test and an rK39-antigen-based dipstick test for the diagnosis of suspected kala-azar in Nepal. Trop Med Int Health (2003) 1.20
The use of DNA hybridization and numerical taxonomy in determining relationships between Trypanosoma brucei stocks and subspecies. Parasitology (1986) 1.20
Evaluation of a urinary antigen-based latex agglutination test in the diagnosis of kala-azar in eastern Nepal. Trop Med Int Health (2004) 1.20
Trypanosoma cruzi: impact of clonal evolution of the parasite on its biological and medical properties. Exp Parasitol (1998) 1.20
A gene expressed only in serum-resistant variants of Trypanosoma brucei rhodesiense. Mol Biochem Parasitol (1989) 1.19
How better drugs could change kala-azar control. Lessons from a cost-effectiveness analysis. Trop Med Int Health (2002) 1.19
Gene activation and re-expression of a Trypanosoma brucei variant surface glycoprotein. EMBO J (1983) 1.19
Trypanosoma cruzi: a considerable phylogenetic divergence indicates that the agent of Chagas disease is indigenous to the native fauna of the United States. Exp Parasitol (2001) 1.19
Universal PCR assays for the differential detection of all Old World Leishmania species. Eur J Clin Microbiol Infect Dis (2010) 1.18
Multi-centre evaluation of repeatability and reproducibility of the direct agglutination test for visceral leishmaniasis. Trop Med Int Health (1999) 1.17
[High correlation between isoenzyme classification and kinetoplast DNA variability in Trypanosoma cruzi]. C R Acad Sci III (1987) 1.17
Identification of six Trypanosoma cruzi lineages by sequence-characterised amplified region markers. Mol Biochem Parasitol (2000) 1.14
Evidence for clonal propagation in natural isolates of Plasmodium falciparum from Venezuela. Proc Natl Acad Sci U S A (2001) 1.14
The ble resistance gene as a new selectable marker for Trypanosoma brucei: fly transmission of stable procyclic transformants to produce antibiotic resistant bloodstream forms. Nucleic Acids Res (1993) 1.14
Inactivation and reactivation of a variant-specific antigen gene in cyclically transmitted Trypanosoma brucei. EMBO J (1985) 1.13
Evidence for hybridization by multilocus enzyme electrophoresis and random amplified polymorphic DNA between Leishmania braziliensis and Leishmania panamensis/guyanensis in Ecuador. J Eukaryot Microbiol (1997) 1.12
Only the serum-resistant bloodstream forms of Trypanosoma brucei rhodesiense express the serum resistance associated (SRA) protein. Ann Soc Belg Med Trop (1992) 1.12
[Antigenic structure of Trypanosoma brucei (protozoa, kinetoplastids). Immunoelectrophoretic analysis and comparative study]. Ann Soc Belg Med Trop (1975) 1.12
Restricted genetic and antigenic diversity of Plasmodium falciparum under mesoendemic transmission in the Venezuelan Amazon. Parasitology (2002) 1.11
Genetic diversity of Pseudomonas aeruginosa strains isolated from ventilated patients with nosocomial pneumonia, cancer patients with bacteremia, and environmental water. Infect Immun (2001) 1.11
Different mechanisms account for the suppression of interleukin 2 production and the suppression of interleukin 2 receptor expression in Trypanosoma brucei-infected mice. Eur J Immunol (1989) 1.10
Experimental Trypanosoma brucei infections selectively suppress both interleukin 2 production and interleukin 2 receptor expression. Eur J Immunol (1987) 1.10
A cellular mechanism for the transformation of a sensory input into a motor command. J Neurosci (2000) 1.09
Stimuli of differentiation regulate RNA elongation in the transcription units for the major stage-specific antigens of Trypanosoma brucei. Nucleic Acids Res (1995) 1.09
A genetic comparison between Brazilian and Bolivian zymodemes of Trypanosoma cruzi. Trans R Soc Trop Med Hyg (1983) 1.09
Dual role of macrophages in the suppression of interleukin 2 production and interleukin 2 receptor expression in trypanosome-infected mice. Eur J Immunol (1989) 1.09
Putative Leishmania hybrids in the Eastern Andean valley of Huanuco, Peru. Acta Trop (1995) 1.08
Evidence for kinetoplast and nuclear DNA homogeneity in Trypanosoma evansi isolates. Mol Biochem Parasitol (1990) 1.08
Central control components of a 'simple' stretch reflex. Trends Neurosci (2000) 1.07
Population structure of Andean Triatoma infestans: allozyme frequencies and their epidemiological relevance. Med Vet Entomol (1998) 1.06
A phylogenetic analysis of the Trypanosoma cruzi genome project CL Brener reference strain by multilocus enzyme electrophoresis and multiprimer random amplified polymorphic DNA fingerprinting. Mol Biochem Parasitol (1998) 1.06
Genetic heterogeneity and phylogenetic status of Leishmania (Leishmania) infantum zymodeme MON-1: epidemiological implications. Parasitology (2001) 1.06
Different behavior of two Trypanosoma cruzi major clones: transmission and circulation in young Bolivian patients. Exp Parasitol (1998) 1.04
The population structure of Neisseria meningitidis serogroup A fits the predictions for clonality. Infect Genet Evol (2001) 1.04
Genetic analysis of leishmania parasites in Ecuador: are Leishmania (Viannia) panamensis and Leishmania (V.) Guyanensis distinct taxa? Am J Trop Med Hyg (1999) 1.02